Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
1.050
-0.060 (-5.41%)
At close: Mar 27, 2026, 4:00 PM EDT
1.055
+0.005 (0.47%)
After-hours: Mar 27, 2026, 6:17 PM EDT
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $29.38 million as of March 27, 2026. Its market cap has decreased by -63.64% in one year.
Market Cap
29.38M
Enterprise Value
-19.81M
1-Year Change
-63.64%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $29.38M, a decrease of -76.06%. That is a compound annual growth rate of -20.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 29.38M | -42.62% |
| Dec 31, 2025 | 51.21M | -84.03% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| INmune Bio | 29.78M |
| Tvardi Therapeutics | 29.74M |
| PDS Biotechnology | 29.63M |
| Evaxion | 29.36M |
| AEON Biopharma | 29.35M |
| Hyperion DeFi | 28.72M |
| Exicure | 28.14M |
| Quantum BioPharma | 27.08M |